N-(4-Carbamimidoyl-benzyl)-2-[6-(3,5-diamino-phenyl)-3-isopropylamino-2-oxo-2H-pyridin-1-yl]-acetamide

ID: ALA142205

Chembl Id: CHEMBL142205

PubChem CID: 10072299

Max Phase: Preclinical

Molecular Formula: C24H29N7O2

Molecular Weight: 447.54

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)Nc1ccc(-c2cc(N)cc(N)c2)n(CC(=O)NCc2ccc(C(=N)N)cc2)c1=O

Standard InChI:  InChI=1S/C24H29N7O2/c1-14(2)30-20-7-8-21(17-9-18(25)11-19(26)10-17)31(24(20)33)13-22(32)29-12-15-3-5-16(6-4-15)23(27)28/h3-11,14,30H,12-13,25-26H2,1-2H3,(H3,27,28)(H,29,32)

Standard InChI Key:  RSRFHMTXQRECCQ-UHFFFAOYSA-N

Associated Targets(Human)

F7 Tchem Coagulation factor VII (948 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
F10 Tclin Coagulation factor X (9693 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
F2 Tclin Thrombin (11687 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
F7 Tchem Coagulation factor VII/tissue factor (740 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 447.54Molecular Weight (Monoisotopic): 447.2383AlogP: 2.10#Rotatable Bonds: 8
Polar Surface Area: 165.04Molecular Species: BASEHBA: 7HBD: 6
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 9#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 11.48CX LogP: -0.26CX LogD: -2.67
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.18Np Likeness Score: -0.88

References

1. Parlow JJ, Kurumbail RG, Stegeman RA, Stevens AM, Stallings WC, South MS..  (2003)  Design, synthesis, and crystal structure of selective 2-pyridone tissue factor VIIa inhibitors.,  46  (22): [PMID:14561089] [10.1021/jm0301686]
2. Gillis EP, Eastman KJ, Hill MD, Donnelly DJ, Meanwell NA..  (2015)  Applications of Fluorine in Medicinal Chemistry.,  58  (21): [PMID:26200936] [10.1021/acs.jmedchem.5b00258]
3. Xie Z, Tian Y, Lv X, Xiao X, Zhan M, Cheng K, Li S, Liao C..  (2018)  The selectivity and bioavailability improvement of novel oral anticoagulants: An overview.,  146  [PMID:29407959] [10.1016/j.ejmech.2018.01.067]

Source